Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.
Identifieur interne : 000217 ( Pmc/Corpus ); précédent : 000216; suivant : 000218Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.
Auteurs : J. Biagi ; R. G. Mackenzie ; M. S. Lim ; M. Sapp ; N. BerinsteinSource :
- Neuro-Oncology [ 1522-8517 ] ; 2000.
Abstract
Primary Hodgkin's disease limited to the CNS is exceedingly rare. Little is known regarding etiologic risk factors, optimal management, and prognosis. A case of Hodgkin's disease confined to the CNS, with cerebrospinal fluid negative for cytology, is described in an immunocompetent patient previously treated for hyperthyroidism with 131I. The patient underwent craniotomy, with resection of two lesions in close proximity within the parenchyma of the temporoparietal lobe. Histopathology revealed classic nodular sclerosing Hodgkin's disease, without evidence of Epstein-Barr viral infection. Treatment included radiation to the whole brain with a boost to the tumor bed. The patient made a full neurologic recovery and remains free of disease recurrence 21 months after treatment. A literature review has identified only 9 additional cases. Seven of 8 evaluable patients remain alive and free of recurrence with a median follow-up of 13 months. The risk factors for this presentation remain undefined. Although follow-up is short, radiotherapy alone appears to provide excellent disease-free survival. Chemotherapy may be reserved for patients with positive cerebrospinal fluid, extracranial disease, or subsequent relapse.
Url:
PubMed: 11265233
PubMed Central: 1920596
Links to Exploration step
PMC:1920596Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.</title>
<author><name sortKey="Biagi, J" sort="Biagi, J" uniqKey="Biagi J" first="J." last="Biagi">J. Biagi</name>
</author>
<author><name sortKey="Mackenzie, R G" sort="Mackenzie, R G" uniqKey="Mackenzie R" first="R. G." last="Mackenzie">R. G. Mackenzie</name>
</author>
<author><name sortKey="Lim, M S" sort="Lim, M S" uniqKey="Lim M" first="M. S." last="Lim">M. S. Lim</name>
</author>
<author><name sortKey="Sapp, M" sort="Sapp, M" uniqKey="Sapp M" first="M." last="Sapp">M. Sapp</name>
</author>
<author><name sortKey="Berinstein, N" sort="Berinstein, N" uniqKey="Berinstein N" first="N." last="Berinstein">N. Berinstein</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">11265233</idno>
<idno type="pmc">1920596</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920596</idno>
<idno type="RBID">PMC:1920596</idno>
<date when="2000">2000</date>
<idno type="wicri:Area/Pmc/Corpus">000217</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000217</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.</title>
<author><name sortKey="Biagi, J" sort="Biagi, J" uniqKey="Biagi J" first="J." last="Biagi">J. Biagi</name>
</author>
<author><name sortKey="Mackenzie, R G" sort="Mackenzie, R G" uniqKey="Mackenzie R" first="R. G." last="Mackenzie">R. G. Mackenzie</name>
</author>
<author><name sortKey="Lim, M S" sort="Lim, M S" uniqKey="Lim M" first="M. S." last="Lim">M. S. Lim</name>
</author>
<author><name sortKey="Sapp, M" sort="Sapp, M" uniqKey="Sapp M" first="M." last="Sapp">M. Sapp</name>
</author>
<author><name sortKey="Berinstein, N" sort="Berinstein, N" uniqKey="Berinstein N" first="N." last="Berinstein">N. Berinstein</name>
</author>
</analytic>
<series><title level="j">Neuro-Oncology</title>
<idno type="ISSN">1522-8517</idno>
<idno type="eISSN">1523-5866</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Primary Hodgkin's disease limited to the CNS is exceedingly rare. Little is known regarding etiologic risk factors, optimal management, and prognosis. A case of Hodgkin's disease confined to the CNS, with cerebrospinal fluid negative for cytology, is described in an immunocompetent patient previously treated for hyperthyroidism with 131I. The patient underwent craniotomy, with resection of two lesions in close proximity within the parenchyma of the temporoparietal lobe. Histopathology revealed classic nodular sclerosing Hodgkin's disease, without evidence of Epstein-Barr viral infection. Treatment included radiation to the whole brain with a boost to the tumor bed. The patient made a full neurologic recovery and remains free of disease recurrence 21 months after treatment. A literature review has identified only 9 additional cases. Seven of 8 evaluable patients remain alive and free of recurrence with a median follow-up of 13 months. The risk factors for this presentation remain undefined. Although follow-up is short, radiotherapy alone appears to provide excellent disease-free survival. Chemotherapy may be reserved for patients with positive cerebrospinal fluid, extracranial disease, or subsequent relapse.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Neuro Oncol</journal-id>
<journal-title>Neuro-Oncology</journal-title>
<issn pub-type="ppub">1522-8517</issn>
<issn pub-type="epub">1523-5866</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">11265233</article-id>
<article-id pub-id-type="pmc">1920596</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Biagi</surname>
<given-names>J.</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>MacKenzie</surname>
<given-names>R. G.</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Lim</surname>
<given-names>M. S.</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Sapp</surname>
<given-names>M.</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Berinstein</surname>
<given-names>N.</given-names>
</name>
</contrib>
</contrib-group>
<aff>Divisions of Medical Oncology and Hematology, Toronto, Ontario, Canada.</aff>
<pub-date pub-type="ppub"><month>10</month>
<year>2000</year>
</pub-date>
<volume>2</volume>
<issue>4</issue>
<fpage>239</fpage>
<lpage>243</lpage>
<abstract><p>Primary Hodgkin's disease limited to the CNS is exceedingly rare. Little is known regarding etiologic risk factors, optimal management, and prognosis. A case of Hodgkin's disease confined to the CNS, with cerebrospinal fluid negative for cytology, is described in an immunocompetent patient previously treated for hyperthyroidism with 131I. The patient underwent craniotomy, with resection of two lesions in close proximity within the parenchyma of the temporoparietal lobe. Histopathology revealed classic nodular sclerosing Hodgkin's disease, without evidence of Epstein-Barr viral infection. Treatment included radiation to the whole brain with a boost to the tumor bed. The patient made a full neurologic recovery and remains free of disease recurrence 21 months after treatment. A literature review has identified only 9 additional cases. Seven of 8 evaluable patients remain alive and free of recurrence with a median follow-up of 13 months. The risk factors for this presentation remain undefined. Although follow-up is short, radiotherapy alone appears to provide excellent disease-free survival. Chemotherapy may be reserved for patients with positive cerebrospinal fluid, extracranial disease, or subsequent relapse.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000217 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000217 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= CobaltMaghrebV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:1920596 |texte= Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:11265233" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CobaltMaghrebV1
This area was generated with Dilib version V0.6.32. |